EUVIMEDEUVIMED entdecken
Crossref

JOSD1 Deubiquitinates Twist1 and Facilitates Epithelial–Mesenchymal Transition in Glioblastoma

Jiaquan Song iD, Wenjin Qiu, Ruting Wei, Wu Cen, Xiaotong Yang, Daijun Shen, Tangfeng Zhang, Yimin Chen, Shibin Song

Cell Biochemistry and Function · 2026-04 · 44 (4)

DOI: 10.1002/cbf.70208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Function, online erschienen am 08.04.2026. Verfasst von Jiaquan Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Twist-Related Protein 1, Epithelial-Mesenchymal Transition, Glioblastoma, Nuclear Proteins. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Science and Technology Foundation of Guizhou Health, Guizhou Provincial Science and Technology Projects, Doctoral Research Launch Foundation, the Affiliated Hospital of Guizhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is a lethal brain tumor where diffuse invasion and a mesenchymal phenotype drive therapy resistance. Maintaining proteostasis through ubiquitin editing is a crucial stress‐adaptive mechanism in cancer, but its role in GBM invasiveness is unclear. We analyzed JOSD1 expression in clinical samples and assessed its correlation with patient survival. Gain‐ and loss‐of‐function studies in GBM cell lines were performed to evaluate the role of JOSD1 in invasion, migration, proliferation, and the regulation of epithelial‐to‐mesenchymal transition (EMT) markers. Protein‐protein interaction, deubiquitination, and cycloheximide chase assays were used to define the mechanistic relationship between JOSD1 and Twist1. Rescue experiments with Twist1 re‐expression were conducted to confirm the functional axis. JOSD1 was markedly upregulated in GBM and high expression correlated with poor patient survival. JOSD1 overexpression promoted invasion, migration, proliferation, and an EMT‐like shift (decreased E‐cadherin, increased N‐cadherin and Vimentin), while its silencing had opposite effects. Mechanistically, JOSD1 directly bound to and deubiquitinated Twist1, preventing its proteasomal degradation and extending its protein half‐life. JOSD1 depletion accelerated Twist1 turnover, and re‐expression of Twist1 rescued the impaired invasiveness and growth in JOSD1‐deficient cells. Conversely, Twist1 knockdown abrogated the pro‐invasive effects of JOSD1 overexpression. Our findings define a JOSD1–Twist1 axis that sustains a mesenchymal, invasive phenotype in GBM by regulating Twist1 protein stability. This links ubiquitin‐dependent proteostasis to GBM pathogenicity, suggesting that targeting JOSD1 may represent a therapeutic strategy for aggressive, mesenchymal GBM. Glioblastoma remains one of the most lethal human cancers, and effective strategies to block its diffuse invasion are urgently needed. Here we identify the deubiquitinase JOSD1 as a previously unrecognized driver of epithelial–mesenchymal transition and invasion in glioblastoma. JOSD1 directly binds and deubiquitinates the transcription factor Twist1, preventing its proteasomal degradation and sustaining a mesenchymal, highly motile phenotype. Genetic depletion inhibition of JOSD1 destabilizes Twist1, suppresses invasion, and attenuates tumor growth in preclinical models. Clinically, JOSD1 is markedly upregulated in glioma tissues and its high expression predicts poor patient survival. Our findings nominate the JOSD1–Twist1 axis as a druggable vulnerability for invasive glioblastoma and support future development of JOSD1‐targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Twist-Related Protein 1Epithelial-Mesenchymal TransitionGlioblastomaNuclear ProteinsBrain NeoplasmsHumansUbiquitinationAnimalsCell Line, TumorCell MovementCell Proliferation

Stichwörter der Autor:innen

JOSD1Twist1deubiquitinationepithelial‐mesenchymal transitionglioblastoma

Substanzen

Twist-Related Protein 1TWIST1 protein, humanNuclear Proteins

Autor:innen und Institutionen

  • Department of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Cardiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
  • Department of Neurosurgery, Yanting County People's Hospital, Nanchong, Sichuan, China.

ORCID-Profile: Jiaquan Song

Förderung

  • Science and Technology Foundation of Guizhou Health
  • Guizhou Provincial Science and Technology Projects
  • Doctoral Research Launch Foundation, the Affiliated Hospital of Guizhou Medical University

Zitieren

APA

Song, J., Qiu, W., Wei, R., Cen, W., Yang, X., Shen, D., Zhang, T., Chen, Y., & Song, S. (2026). JOSD1 Deubiquitinates Twist1 and Facilitates Epithelial–Mesenchymal Transition in Glioblastoma. Cell Biochemistry and Function, 44(4). https://doi.org/10.1002/cbf.70208

Vancouver

Song J, Qiu W, Wei R, Cen W, Yang X, Shen D, et al. JOSD1 Deubiquitinates Twist1 and Facilitates Epithelial–Mesenchymal Transition in Glioblastoma. Cell Biochemistry and Function. 2026;44(4). doi:10.1002/cbf.70208

BibTeX
@article{Song2026,
  author = {Song, Jiaquan and Qiu, Wenjin and Wei, Ruting and Cen, Wu and Yang, Xiaotong and Shen, Daijun and Zhang, Tangfeng and Chen, Yimin and Song, Shibin},
  title = {JOSD1 Deubiquitinates Twist1 and Facilitates Epithelial–Mesenchymal Transition in Glioblastoma},
  journal = {Cell Biochemistry and Function},
  year = {2026},
  volume = {44},
  number = {4},
  doi = {10.1002/cbf.70208}
}
Kostenlos starten →